Safety and immunogenicity of an optimized self-replicating RNA platform for low dose or single dose vaccine applications: a randomized, open label Phase I study in healthy volunteers
针对低剂量或单剂量疫苗应用的优化自复制 RNA 平台的安全性和免疫原性：一项针对健康志愿者的随机、开放标签 I 期研究
期刊:Nature Communications
影响因子:14.7
doi:10.1038/s41467-025-55843-9
Christian J Maine #, Shigeki J Miyake-Stoner #, Darina S Spasova #, Gaelle Picarda, Annie C Chou, Emily D Brand, Melanie D Olesiuk, Christine C Domingo, Hunter J Little, Thomas T Goodman, Jacqueline L Posy, Jasmin Gonzalez, Terrina L Bayone, Jessica Sparks, Ebony N Gary, Zhi Xiang, Nicholas J Tursi,
